Literature DB >> 8432823

Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.

F Dromer1, E Gueho, O Ronin, B Dupont.   

Abstract

The importance of epidemiological studies of cryptococcosis has increased since the beginning of the AIDS epidemic. Cryptococcus neoformans exists in two varieties defining four serotypes, Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). The varieties are easy to distinguish by their differences of growth on diagnostic media. We propose here an easy serotyping method combining diagnostic media and a direct immunofluorescence assay with one monoclonal antibody (E1) specific for cryptococcal polysaccharide. The method was validated by the blinded testing of four to five reference strains of each serotype. Immunofluorescence patterns were characteristic of a given serotype provided that the variety of the strain had been defined before. For C. neoformans var. neoformans, a bright, homogeneous staining with several cell aggregates was characteristics of serotype A, whereas only a few serotype D cells were positive. For C. neoformans var. gattii, a completely negative isolate was serotype C, whereas the population of serotype B included a majority of negative cells but also included positive cells with a speckled pattern. The method was then used to serotype 156 clinical isolates from France and isolates from areas where C. neoformans var. gattii was endemic before the AIDS epidemic (13 strains from Rwanda and Zaire and 5 strains from Australia). The specificity of E1 was defined by its reactivity with various Cryptococcus spp. and analyzed according to the described cryptococcal antigenic factors. We conclude from this study that E1 provides a rapid and reliable means to serotype multiple isolates of C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432823      PMCID: PMC262765          DOI: 10.1128/jcm.31.2.359-363.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Isolation of Cryptococcus neoformans gattii from a patient with AIDS in southern California.

Authors:  M N Clancy; J Fleischmann; D H Howard; K J Kwon-Chung; R Y Shimizu
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

2.  Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.

Authors:  R A Fromtling; G K Abruzzo; G S Bulmer
Journal:  Mycopathologia       Date:  1986-04       Impact factor: 2.574

3.  Disseminated cryptococcosis due to Cryptococcus neoformans variety gattii in a Canadian patient with AIDS.

Authors:  G St-Germain; G Noël; K J Chung
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

4.  Rapid identification of the two varieties of Cryptococcus neoformans by D-proline assimilation.

Authors:  R Dufait; R Velho; C De Vroey
Journal:  Mykosen       Date:  1987-10

5.  Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.

Authors:  C Spiropulu; R A Eppard; E Otteson; T R Kozel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

Authors:  K J Kwon-Chung; I Polacheck; J E Bennett
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

7.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Cryptococcal meningitis in patients with AIDS.

Authors:  W E Dismukes
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

9.  Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.

Authors:  R Ikeda; T Shinoda; Y Fukazawa; L Kaufman
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

Review 10.  Capsular polysaccharides of Cryptococcus neoformans.

Authors:  A K Bhattacharjee; J E Bennett; C P Glaudemans
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct
View more
  29 in total

Review 1.  Developments in fungal taxonomy.

Authors:  J Guarro; A M Stchigel
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  Detection of single cells of Cryptococcus neoformans in clinical samples by solid-phase cytometry.

Authors:  T G M Bauters; D Swinne; V Stove; H J Nelis
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  DNA typing suggests pigeon droppings as a source of pathogenic Cryptococcus neoformans serotype D.

Authors:  D Garcia-Hermoso; S Mathoulin-Pélissier; B Couprie; O Ronin; B Dupont; F Dromer
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule.

Authors:  Marcellene A Gates-Hollingsworth; Thomas R Kozel
Journal:  Mol Microbiol       Date:  2009-09-02       Impact factor: 3.501

5.  Cas3p belongs to a seven-member family of capsule structure designer proteins.

Authors:  Frédérique Moyrand; Yun C Chang; Uwe Himmelreich; Kyung J Kwon-Chung; Guilhem Janbon
Journal:  Eukaryot Cell       Date:  2004-12

6.  UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis.

Authors:  Frédérique Moyrand; Guilhem Janbon
Journal:  Eukaryot Cell       Date:  2004-12

7.  A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.

Authors:  Mark Probert; Xin Zhou; Margaret Goodall; Simon A Johnston; Ewa Bielska; Elizabeth R Ballou; Robin C May
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

8.  Genetic multilocus studies of different strains of Cryptococcus neoformans: taxonomy and genetic structure.

Authors:  S Bertout; F Renaud; D Swinne; M Mallié; J M Bastide
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.

Authors:  S P Franzot; I F Salkin; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.

Authors:  Javier García-Rivera; Yun C Chang; K J Kwon-Chung; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.